SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-002807
Filing Date
2020-01-10
Accepted
2020-01-10 06:03:07
Documents
9
Period of Report
2020-01-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm201678d1_8k.htm 8-K 35982
2 EXHIBIT 1.1 tm201678d1_ex1-1.htm EX-1.1 77733
3 EXHIBIT 4.1 tm201678d1_ex4-1.htm EX-4.1 101871
4 EXHIBIT 4.2 tm201678d1_ex4-2.htm EX-4.2 106109
5 EXHIBIT 5.1 tm201678d1_ex5-1.htm EX-5.1 13868
6 EXHIBIT 10.1 tm201678d1_ex10-1.htm EX-10.1 264134
7 EXHIBIT 99.1 tm201678d1_ex99-1.htm EX-99.1 10422
8 GRAPHIC tm201678d1_ex1-1img001.jpg GRAPHIC 9731
9 GRAPHIC tm201678d1_ex5-1img001.jpg GRAPHIC 6769
  Complete submission text file 0001104659-20-002807.txt   634739
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 20519363
SIC: 2834 Pharmaceutical Preparations